Wells Fargo & Company Dia Medica Therapeutics Inc. Transaction History

Wells Fargo & Company

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$2.58 - $3.23 $7 - $9	3 Added 1.74%	175 $0
Q4 2023 Feb 09, 2024	BUY	$2.05 - $2.99 $18 - $26	9 Added 5.52%	172 $0
Q3 2023 Nov 13, 2023	BUY	$2.56 - $4.4 $120 - $206	47 Added 40.52%	163 $0
Q2 2023 Aug 15, 2023	BUY	$1.53 - $4.4 $6 - $17	4 Added 3.57%	116 $0
Q1 2023 May 12, 2023	BUY	$1.32 - $1.89 $2 - $3	2 Added 1.82%	112 $0
Q4 2022 Feb 13, 2023	BUY	$1.13 - $1.62 $3 - $4	3 Added 2.8%	110 $0
Q3 2022 Nov 14, 2022	SELL	$1.2 - $2.07 $84 - $144	-70 Reduced 39.55%	107 $0
Q2 2022 Aug 12, 2022	BUY	$1.86 - $2.62 $26 - $36	14 Added 8.59%	177 $0
Q1 2022 May 16, 2022	BUY	$2.29 - $3.88 $2 - $3	1 Added 0.62%	163 $0
Q4 2021 Feb 14, 2022	BUY	$3.43 - $4.65 $161 - $218	47 Added 40.87%	162 $1,000
Q3 2021 Nov 15, 2021	BUY	$3.1 - $4.32 $31 - $43	10 Added 9.52%	115 $0
Q2 2021 Aug 16, 2021	SELL	$4.45 - $9.91 $4 - $9	-1 Reduced 0.94%	105 $0
Q1 2021 May 13, 2021	SELL	$7.76 - $10.43 $15,520 - $20,860	-2,000 Reduced 94.97%	106 $1,000
Q4 2020 Feb 09, 2021	BUY	$4.13 - $10.14 $128 - $314	31 Added 1.49%	2,106 $21,000
Q3 2020 Nov 05, 2020	BUY	$3.91 - $7.15 $31 - $57	8 Added 0.39%	2,075 $8,000
Q2 2020 Aug 13, 2020	BUY	$2.6 - $7.32 $5,200 - $14,640	2,000 Added 2985.07%	2,067 $14,000
Q1 2020 May 14, 2020	BUY	$2.25 - $5.64 $150 - $377	67 New	67 $0

3.87M

1.3K

Ticker DMAC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,443,100
Market Cap $116M
Description
DiaMedica Therapeutics Inc., a clinical stage biopharmaceutical company, develops treatments for neurological and kidney diseases. The company's lead drug candidate is DM199, a recombinant human tissue kallikrein-1 protein, which is in Phase 2 REDUX trial for the treatment of patients with moderate or severe chronic kidney disease caused by Type...

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

Stay updated on Wells Fargo & Company with notifications on news.